29535332|t|Rare human Caspase-6-R65W and Caspase-6-G66R variants identify a novel regulatory region of Caspase-6 activity.
29535332|a|The cysteine protease Caspase-6 (Casp6) is a potential therapeutic target of Alzheimer Disease (AD) and age-dependent cognitive impairment. To assess if Casp6 is essential to human health, we investigated the effect of CASP6 variants sequenced from healthy humans on Casp6 activity. Here, we report the effects of two rare Casp6 amino acid polymorphisms, R65W and G66R, on the catalytic function and structure of Casp6. The G66R substitution eliminated and R65W substitution significantly reduced Casp6 catalytic activity through impaired substrate binding. In contrast to wild-type Casp6, both Casp6 variants were unstable and inactive in transfected mammalian cells. In addition, Casp6-G66R acted as a dominant negative inhibitor of wild-type Casp6. The R65W and G66R substitutions caused perturbations in substrate recognition and active site organization as revealed by molecular dynamics simulations. Our results suggest that full Casp6 activity may not be essential for healthy humans and support the use of Casp6 inhibitors against Casp6-dependent neurodegeneration in age-dependent cognitive impairment and AD. Furthermore, this work illustrates that studying natural single amino acid polymorphisms of enzyme drug targets is a promising approach to uncover previously uncharacterized regulatory sites important for enzyme activity.
29535332	5	10	human	Species	9606
29535332	11	20	Caspase-6	Gene	839
29535332	21	25	R65W	ProteinMutation	tmVar:p|SUB|R|65|W;HGVS:p.R65W;VariantGroup:1;CorrespondingGene:839;RS#:61731769;CorrespondingSpecies:9606;CA#:3041536
29535332	30	39	Caspase-6	Gene	839
29535332	40	44	G66R	ProteinMutation	tmVar:p|SUB|G|66|R;HGVS:p.G66R;VariantGroup:0;CorrespondingGene:839;RS#:1042887;CorrespondingSpecies:9606;CA#:103682262
29535332	92	101	Caspase-6	Gene	839
29535332	134	143	Caspase-6	Gene	839
29535332	145	150	Casp6	Gene	839
29535332	189	206	Alzheimer Disease	Disease	MESH:D000544
29535332	208	210	AD	Disease	MESH:D000544
29535332	230	250	cognitive impairment	Disease	MESH:D003072
29535332	265	270	Casp6	Gene	839
29535332	287	292	human	Species	9606
29535332	331	336	CASP6	Gene	839
29535332	369	375	humans	Species	9606
29535332	379	384	Casp6	Gene	839
29535332	435	440	Casp6	Gene	839
29535332	467	471	R65W	ProteinMutation	tmVar:p|SUB|R|65|W;HGVS:p.R65W;VariantGroup:1;CorrespondingGene:839;RS#:61731769;CorrespondingSpecies:9606;CA#:3041536
29535332	476	480	G66R	ProteinMutation	tmVar:p|SUB|G|66|R;HGVS:p.G66R;VariantGroup:0;CorrespondingGene:839;RS#:1042887;CorrespondingSpecies:9606;CA#:103682262
29535332	525	530	Casp6	Gene	839
29535332	536	540	G66R	ProteinMutation	tmVar:p|SUB|G|66|R;HGVS:p.G66R;VariantGroup:0;CorrespondingGene:839;RS#:1042887;CorrespondingSpecies:9606;CA#:103682262
29535332	569	573	R65W	ProteinMutation	tmVar:p|SUB|R|65|W;HGVS:p.R65W;VariantGroup:1;CorrespondingGene:839;RS#:61731769;CorrespondingSpecies:9606;CA#:3041536
29535332	609	614	Casp6	Gene	839
29535332	695	700	Casp6	Gene	839
29535332	707	712	Casp6	Gene	839
29535332	794	799	Casp6	Gene	839
29535332	800	804	G66R	ProteinMutation	tmVar:p|SUB|G|66|R;HGVS:p.G66R;VariantGroup:0;CorrespondingGene:839;RS#:1042887;CorrespondingSpecies:9606;CA#:103682262
29535332	857	862	Casp6	Gene	839
29535332	868	872	R65W	ProteinMutation	tmVar:p|SUB|R|65|W;HGVS:p.R65W;VariantGroup:1;CorrespondingGene:839;RS#:61731769;CorrespondingSpecies:9606;CA#:3041536
29535332	877	881	G66R	ProteinMutation	tmVar:p|SUB|G|66|R;HGVS:p.G66R;VariantGroup:0;CorrespondingGene:839;RS#:1042887;CorrespondingSpecies:9606;CA#:103682262
29535332	1048	1053	Casp6	Gene	839
29535332	1096	1102	humans	Species	9606
29535332	1126	1131	Casp6	Gene	839
29535332	1151	1156	Casp6	Gene	839
29535332	1167	1184	neurodegeneration	Disease	MESH:D019636
29535332	1202	1222	cognitive impairment	Disease	MESH:D003072
29535332	1227	1229	AD	Disease	MESH:D000544
29535332	Association	MESH:D019636	839
29535332	Association	MESH:D003072	839
29535332	Association	MESH:D000544	839

